With this new webinar we want to answer this question
Why 3D tissue models and microfluidic systems are important for modeling healthy and leukemic lymphocytes dissemination in-vitro? Our guest speaker, Dr. Cristina Scielzo, will talk about her recent research in this topic, by adopting innovative approches like microgravity bioreactor and 3D printing; she will also present her preliminary results about the adoption of MIVO device for culturing lymphocytes.
ABOUT THE SPEAKER
Dr. Cristina Scielzo received her doctor degree in Medical Biotechnology at Università Vita-Salute San Raffaele and in 2012 obtained her PhD in Physiology at University of Milano. Since 2020 she is Group Leader of the Unit of Malignant B cell biology and 3D modelling at IRCCS Ospedale San Raffaele in the division of Experimental Oncology. She has published >40 articles in peer-reviewed journals. Her work has been cited > 3900 times, with an H-index of 31 and IF > 350.
Her team is currently studying the tumor cell/microenvironment interactions in chronic lymphocytic leukemia (CLL). In parallel, they are developing new advanced 3D in-vitro co-culture systems by prototyping a bench-top 3D bio-printer and exploiting different bioreactors with the goal to establish a 3D multi-organ system to dissect the leukemia/lymphoma-microenvironment cross-talk in the tissues.